Royalty Pharma Plc Stock Performance
as on November 8, 2025 at 2:29 am IST
Day's Low
Day's High
$38.39$40.1
0.42%
Downside
4.02%
Upside
52 Week's Low
52 Week's High
$24.05$41.2437.61%
Downside
6.98%
Upside
Royalty Pharma Plc share price movements today
- Previous Close
- $40.78
- Open
- $38.87
- Volume
- 7.3M
- Day's Low - High
- $38.39 - $40.1
- 52 Week Low - High
- $24.05 - $41.24
Royalty Pharma Plc Historical Returns
- 1 Month Return
- + 7.05 %
- 3 Month Return
- + 2.61 %
- 1 Year Return
- + 47.12 %
- 3 Year Return
- -9.67 %
- 5 Year Return
- -4.17 %
Royalty Pharma Plc Stock Fundamentals & Key Indicators
Check Royalty Pharma Plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$23.5B
EPS (TTM)
4.6306
Dividend Yield
2.79%
Quarterly Earnings Growth YOY
-0.45%
PE Ratio (TTM)
23.3
Industry PE ratio
19.200384615384614
PEG Ratio
2.7801
EBITDA
1.5B
Revenue (TTM)
2.3B
Profit Margin
32.55%
Return On Equity TTM
17.29%
Royalty Pharma Plc Stock Valuation
Track how Royalty Pharma Plc P/E has moved over time to understand its valuation trends.
Royalty Pharma Plc in the last 5 years
Lowest (5.79x)
December 31, 2023
Industry (19.20x)
November 8, 2025
Today (23.30x)
November 8, 2025
Highest (18.03x)
March 31, 2021
Today’s Price to Earnings Ratio: 23.30x
Royalty Pharma Plc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Royalty Pharma Plc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $23.5B | -4.17% | 23.3 | 32.55% | |
| BUY | $40.5B | 482.44% | -16.34 | -264.83% | |
| BUY | $58.2B | 238.64% | 1420.94 | 1.36% | |
| BUY | $105.6B | 85.89% | 29.33 | 31.35% | |
| BUY | $68.0B | 13.75% | 15.51 | 32.13% |
Stock Returns calculator for Royalty Pharma Plc Stock including INR - Dollar returns
The Royalty Pharma Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Royalty Pharma Plc investment value today
Current value as on today
₹1,52,228
Returns
₹52,228
(+52.23%)
Returns from Royalty Pharma Plc Stock
₹47,081 (+47.08%)
Dollar Returns*
₹5,147 (+5.15%)
Analyst Recommendation on Royalty Pharma Plc Stock
Based on 14 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 14 analysts, 85.71% of analysts recommend a 'BUY' rating for Royalty Pharma Plc. Average target price of $45.54
Royalty Pharma Plc Share Price Target
Get share price movements and forecasts by analysts on Royalty Pharma Plc.
What analysts predicted
15.35%UPSIDE
Target Price
$45.54
Current Price
$38.55
Analyzed by
14 Analysts
Target
$45.54
Royalty Pharma Plc target price $45.54, a slight upside of 15.35% compared to current price of $38.55. According to 14 analysts rating.
Royalty Pharma Plc Stock’s Investor Sentiment and Interest
Search interest for Royalty Pharma Plc Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Royalty Pharma Plc Quarterly Profit & Loss
All numbers in Millions USD
Royalty Pharma Plc Annual Profit & Loss
All numbers in Millions USD
Royalty Pharma Plc Quarterly Cash Flow
All numbers in Millions USD
Royalty Pharma Plc Annual Cash Flow
All numbers in Millions USD
Royalty Pharma Plc News & Key Events
Today's Timeline - 05 November
Wed, 06:05 PM
-Royalty Pharma reports Q3 2025 results, raising full-year guidance for Portfolio Receipts to $3.2-$3.25 billion, reflecting strong performance.
Wed, 06:50 PM
-Royalty Pharma's Q3 profit falls due to higher expenses, despite revenue growth; net income drops to $288 million from $544 million.
Wed, 06:55 PM
-Royalty Pharma beats Q3 earnings and revenue estimates, reporting EPS of $1.17 and revenue of $814 million, surpassing expectations.
Today's Timeline - 05 November
Thu, 05:53 AM
-Royalty Pharma's earnings soar 52% as margins surge, but legal disputes and revenue risks temper enthusiasm for stock valuation.
Insights on Royalty Pharma Plc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 30.17M → 288.21M (in $), with an average increase of 89.5% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 568.24M → 609.29M (in $), with an average increase of 3.4% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, RPRX stock has moved up by 8.6%
NO EFFECTAgainst Peers
In the last 3 years, Insmed Incorporated has given 897.2% return, outperforming this stock by 901.7%
- NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 152.5% return, outperforming this stock by 96.9%
About Royalty Pharma Plc
| Organisation | Royalty Pharma Plc |
| Headquarters | 110 East 59th Street, New York, NY, United States, 10022 |
| Industry | Health Technology |
| CEO | Mr. Pablo Gerardo Legorreta |
| E-voting on shares | Click here to vote |
Key Management of Royalty Pharma Plc
Name | Title |
|---|---|
Mr. George Wingate Lloyd | Executive VP of Investments & Chief Legal Officer |
Dr. Marshall Jonathan Urist M.D., Ph.D. | Executive Vice President of Research & Investments |
Mr. Arthur Richard McGivern J.D. | Executive Vice President of Investments & General Counsel |
Mr. Pablo Gerardo Legorreta | Founder, Chairman of the Board & CEO |
Mr. Terrance P. Coyne | Executive VP & CFO |
Mr. Christopher Hite | Vice Chairman & Executive VP |
Mr. Ashwin Pai M.D. | Executive Vice President of Investments |
Mr. Eric Cornelius Schneider | Senior VP & Chief Technology Officer |
Dr. James Folmar Reddoch Ph.D. | Executive VP of Investments & Chief Scientific Officer |
Mr. George Grofik C.F.A., CPA | Senior VP and Head of Investor Relations & Communications |
FAQs
What is Royalty Pharma Plc share price today?
Royalty Pharma Plc share price today is $38.55 as on at the close of the market. Royalty Pharma Plc share today touched a day high of $40.1 and a low of $38.39.
What is the 52 week high and 52 week low for Royalty Pharma Plc share?
Royalty Pharma Plc share touched a 52 week high of $41.24 on and a 52 week low of $24.05 on . Royalty Pharma Plc stock price today i.e. is closed at $38.55,which is 6.52% down from its 52 week high and 60.29% up from its 52 week low.
What is Royalty Pharma Plc's market capitalisation today?
Royalty Pharma Plc market capitalisation is $0.02T as on .
How to invest in Royalty Pharma Plc Stock (RPRX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Royalty Pharma Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Royalty Pharma Plc Shares that will get you 0.0389 shares as per Royalty Pharma Plc share price of $38.55 per share as on November 8, 2025 at 2:29 am IST.
What is the minimum amount required to buy Royalty Pharma Plc Stock (RPRX) from India?
Indian investors can start investing in Royalty Pharma Plc (RPRX) shares with as little as ₹88.66 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.60 in Royalty Pharma Plc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Royalty Pharma Plc share’s latest price of $38.55 as on November 8, 2025 at 2:29 am IST, you will get 0.2594 shares of Royalty Pharma Plc. Learn more about
fractional shares .
What are the returns that Royalty Pharma Plc has given to Indian investors in the last 5 years?
Royalty Pharma Plc stock has given -4.17% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?